Edition:
United States

Koninklijke DSM NV (DSMN.AS)

DSMN.AS on Amsterdam Stock Exchange

66.16EUR
26 May 2017
Change (% chg)

€0.24 (+0.36%)
Prev Close
€65.92
Open
€65.80
Day's High
€66.16
Day's Low
€65.44
Volume
489,048
Avg. Vol
707,860
52-wk High
€68.22
52-wk Low
€48.16

DSMN.AS

Chart for DSMN.AS

About

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties. Its Performance... (more)

Overall

Beta: 0.77
Market Cap(Mil.): €12,003.08
Shares Outstanding(Mil.): 181.43
Dividend: 1.20
Yield (%): 2.65

Financials

  DSMN.AS Industry Sector
P/E (TTM): 16.34 16.98 37.00
EPS (TTM): 4.05 -- --
ROI: 5.34 10.10 11.84
ROE: 12.25 13.40 15.25

Thermo Fisher to buy Patheon for $5.2 bln to expand biopharma services

Thermo Fisher Scientific Inc said on Monday it would buy Patheon NV, a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry.

May 15 2017

Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services

Thermo Fisher Scientific Inc said on Monday it would buy Patheon NV , a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry. | Video

May 15 2017

UPDATE 4-Thermo Fisher to buy Patheon for $5.2 bln to expand biopharma services

* Thermo Fisher is world's biggest maker of scientific instruments

May 15 2017

DSM to tender Patheon stake to Thermo Fisher

Dutch food supplement maker DSM will tender its stake in U.S. drug ingredient maker Patheon to Thermo Fisher Scientific , DSM said on Monday.

May 15 2017

UPDATE 1-DSM to tender Patheon stake to Thermo Fisher

May 15 Dutch food supplement maker DSM will tender its stake in U.S. drug ingredient maker Patheon to Thermo Fisher Scientific, DSM said on Monday.

May 15 2017

DSM to tender Patheon stake to Thermo Fisher

May 15 Dutch food supplement maker DSM will tender its stake in U.S. drug ingredient maker Patheon to Thermo Fisher Scientific, DSM said on Monday.

May 15 2017

BRIEF-DSM announces Thermo Fisher will commence tender offer to acquire all shares of Patheon

* BOARD OF DIRECTORS OF PATHEON N.V., COMPANY IN WHICH DSM HOLDS APPROXIMATELY 48.7 MILLION ORDINARY SHARES, UNANIMOUSLY APPROVED ACQUISITION OF PATHEON BY THERMO FISHER SCIENTIFIC INC.

May 15 2017

BRIEF-Royal DSM to make equity investment in Amyris

* Royal DSM to make equity investment in amyris with the purpose of establishing a long-term relationship Source text for Eikon: Further company coverage:

May 08 2017

BRIEF-Royal DSM to make equity investment in Amyris

* Royal DSM to make equity investment in Amyris with the purpose of establishing a long-term relationship Source text for Eikon: Further company coverage:

May 08 2017

BRIEF-Amyris announces agreements for up to $95 mln in equity financing

* Amyris announces agreements for up to $95 million in equity financing and in-process initiative to significantly reduce debt

May 08 2017

More From Around the Web

Earnings vs. Estimates